INO Pipeline candidate Human Factor VIII protein for hemophilia, is said to affect 1 out of 5,000 male births or 66,000 patients whom (46%) of which suffer from severe hemophilia in the 8 major global markets, as reported in Inovio's Jan 19 2026 presentation to the Genomics Biodata Festival.

INO Pipeline candidate Human Factor VIII protein for hemophilia, is said to affect 1 out of 5,000 male births or 66,000 patients whom (46%) of which suffer from severe hemophilia in the 8 major global markets, as reported in Inovio's Jan 19 2026 presentation to the Genomics Biodata Festival.